Tech Company Financing Transactions
Reverse Medical Funding Round
Reverse Medical secured a $14 million Series B financing round on 3/30/2010. Investors included BioStar Private Equity Fund, Early Stage Partners and Emergent Medical Partners.
Transaction Overview
Company Name
Announced On
3/30/2010
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Series B
Investors
Proceeds Purpose
This financing will allow Reverse to continue our rapid progress toward worldwide commercialization and profitability.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
13700 Alton Parkway 167
Irvine, CA 92618
USA
Irvine, CA 92618
USA
Phone
Website
Email Address
Overview
Reverse Medical is a privately held medical device company focused on expanding the endovascular management of acute stroke, neuro and peripheral vascular disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Valko
Chief Technical Officer
Brian Strauss
VP - Engineering
Lynn Shimada
VP - Sales
Alex Thomson
Browse more venture capital transactions:
Prev: 3/30/2010: MuleSoft venture capital transaction
Next: 3/30/2010: Biocept venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs